Furthermore, a recent study showed that CCDC183-AS1 is involved in bladder cancer (BC) progression via an MITF/CCDC183-AS1/miR-4731-5p/TCF7L2 signaling axis [47], in which TCF7L2 was identified as an essential gene in the modulation of aerobic glycolysis (the Warburg effect) [48,49,50]. The gene discussed is CCDC183; the disease is urinary bladder carcinoma.